
Illumina Appoints Agilent Executive Jacob Thaysen as New CEO
Illumina, a global leader in DNA sequencing and array-based technologies, has appointed Jacob Thaysen, Ph.D., as its new Chief Executive Officer. Thaysen, currently the senior vice president of Agilent Technologies and president of its Life Sciences and Applied Markets Group, will assume the role on September 25, 2023. With his extensive background in genomics and technology, Thaysen is expected to contribute to Illumina's mission and drive the company's growth.
